Comparison of gentamicin C1 and (C1a, C2)-levels in patients

Roger L. Nation*, Geoffrey W. Peng, Win L. Chiou, James Malow

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Abstract

A high performance liquid chromatographic (HPLC) assay method has been used to measure gentamicin serum concentrations in patients receiving gentamicin complex. The HPLC method resolves gentamicin C1 from the other two components, C1a and C2; gentamicin C1a and C2 cochromatograph. In the analysis of 46 serum samples collected from 16 patients it was found that the mean ratio (PHR) of the peak height of gentamicin C1 to the height of the peak due to components C1a and C2 was 0.53±0.05; this value agreed well with the PHR's usually found from the HPLC analysis of aqueous solutions of gentamicin complex or of gentamicin dosage forms. In an additional two patients, the HPLC analysis of a sample of the gentamicin dosage form administered, a urine sample, and serum samples, resulted in almost identical PHR's for the respective patients. Finally, similar results were obtained from an experiment in a rabbit. It was concluded that the disposition of all three components of gentamicin complex are the same or very similar.

Original languageEnglish
Pages (from-to)459-462
Number of pages4
JournalEuropean Journal of Clinical Pharmacology
Volume13
Issue number6
DOIs
Publication statusPublished - 1 Nov 1978
Externally publishedYes

Keywords

  • disposition in patients
  • Gentamicin C, C, and C
  • quantitative high pressure liquid chromatography

Cite this

Nation, Roger L. ; Peng, Geoffrey W. ; Chiou, Win L. ; Malow, James. / Comparison of gentamicin C1 and (C1a, C2)-levels in patients. In: European Journal of Clinical Pharmacology. 1978 ; Vol. 13, No. 6. pp. 459-462.
@article{b5a36c1bf1ec485091d0e2ae32539065,
title = "Comparison of gentamicin C1 and (C1a, C2)-levels in patients",
abstract = "A high performance liquid chromatographic (HPLC) assay method has been used to measure gentamicin serum concentrations in patients receiving gentamicin complex. The HPLC method resolves gentamicin C1 from the other two components, C1a and C2; gentamicin C1a and C2 cochromatograph. In the analysis of 46 serum samples collected from 16 patients it was found that the mean ratio (PHR) of the peak height of gentamicin C1 to the height of the peak due to components C1a and C2 was 0.53±0.05; this value agreed well with the PHR's usually found from the HPLC analysis of aqueous solutions of gentamicin complex or of gentamicin dosage forms. In an additional two patients, the HPLC analysis of a sample of the gentamicin dosage form administered, a urine sample, and serum samples, resulted in almost identical PHR's for the respective patients. Finally, similar results were obtained from an experiment in a rabbit. It was concluded that the disposition of all three components of gentamicin complex are the same or very similar.",
keywords = "disposition in patients, Gentamicin C, C, and C, quantitative high pressure liquid chromatography",
author = "Nation, {Roger L.} and Peng, {Geoffrey W.} and Chiou, {Win L.} and James Malow",
year = "1978",
month = "11",
day = "1",
doi = "10.1007/BF00566326",
language = "English",
volume = "13",
pages = "459--462",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer-Verlag London Ltd.",
number = "6",

}

Comparison of gentamicin C1 and (C1a, C2)-levels in patients. / Nation, Roger L.; Peng, Geoffrey W.; Chiou, Win L.; Malow, James.

In: European Journal of Clinical Pharmacology, Vol. 13, No. 6, 01.11.1978, p. 459-462.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Comparison of gentamicin C1 and (C1a, C2)-levels in patients

AU - Nation, Roger L.

AU - Peng, Geoffrey W.

AU - Chiou, Win L.

AU - Malow, James

PY - 1978/11/1

Y1 - 1978/11/1

N2 - A high performance liquid chromatographic (HPLC) assay method has been used to measure gentamicin serum concentrations in patients receiving gentamicin complex. The HPLC method resolves gentamicin C1 from the other two components, C1a and C2; gentamicin C1a and C2 cochromatograph. In the analysis of 46 serum samples collected from 16 patients it was found that the mean ratio (PHR) of the peak height of gentamicin C1 to the height of the peak due to components C1a and C2 was 0.53±0.05; this value agreed well with the PHR's usually found from the HPLC analysis of aqueous solutions of gentamicin complex or of gentamicin dosage forms. In an additional two patients, the HPLC analysis of a sample of the gentamicin dosage form administered, a urine sample, and serum samples, resulted in almost identical PHR's for the respective patients. Finally, similar results were obtained from an experiment in a rabbit. It was concluded that the disposition of all three components of gentamicin complex are the same or very similar.

AB - A high performance liquid chromatographic (HPLC) assay method has been used to measure gentamicin serum concentrations in patients receiving gentamicin complex. The HPLC method resolves gentamicin C1 from the other two components, C1a and C2; gentamicin C1a and C2 cochromatograph. In the analysis of 46 serum samples collected from 16 patients it was found that the mean ratio (PHR) of the peak height of gentamicin C1 to the height of the peak due to components C1a and C2 was 0.53±0.05; this value agreed well with the PHR's usually found from the HPLC analysis of aqueous solutions of gentamicin complex or of gentamicin dosage forms. In an additional two patients, the HPLC analysis of a sample of the gentamicin dosage form administered, a urine sample, and serum samples, resulted in almost identical PHR's for the respective patients. Finally, similar results were obtained from an experiment in a rabbit. It was concluded that the disposition of all three components of gentamicin complex are the same or very similar.

KW - disposition in patients

KW - Gentamicin C, C, and C

KW - quantitative high pressure liquid chromatography

UR - http://www.scopus.com/inward/record.url?scp=0017876662&partnerID=8YFLogxK

U2 - 10.1007/BF00566326

DO - 10.1007/BF00566326

M3 - Article

AN - SCOPUS:0017876662

VL - 13

SP - 459

EP - 462

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 6

ER -